Navigation Links
Royalty Pharma Announces Proposal To Acquire Elan
Date:2/25/2013

of the Irish Takeover Rules, all "dealings" in "relevant securities" of Elan by Elan or Royalty Pharma, or by any of their respective "associates" must also be disclosed by no later than 12 noon (Dublin time) on the "business day" following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed can be found on the Irish Takeover Panel's website at www.irishtakeoverpanel.ie.

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities.  In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Irish Takeover Rules, which can be found on the Irish Takeover Panel's website.

If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, please consult the Irish Takeover Panel's website at www.irishtakeoverpanel.ie or contact the Irish Takeover Panel on telephone number +353 (0)1 678 9020; fax number +353 (0)1 678 9289.

Forward Looking Statements This announcement may include certain "forward looking statements" with respect to the business, strategy and plans of Elan and Royalty Pharma and their respective expectations relating to the Possible Offer and their future financial condition and performance. Statements that are not historical facts, including statements about Elan or Royalty Pharma or their respective management's beliefs and expectations, are forward looking statements. Words such as "believes", "anticipates", "estimates", "expects", "intends", "aims", "potential", "will", "would", "could",
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Royalty Rates Take Center Stage in Biopharma Dealmaking
2. Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Response to Citizens Petition
3. Health Outcomes Liaisons (HOLs) Serve as Key Bridge between Pharmaceutical Sector and Managed Care Groups
4. Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
5. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
6. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2012
7. Pharmaceutical Leader Boehringer Ingelheim Selects Republica as Cross-Cultural Marketing Agency
8. Tomorrows Outlook in Todays Market - Research Report on Toyota Motor Corporation, Honda Motor Co., Ltd., Yahoo! Inc., AOL, Inc. and Aegerion Pharmaceuticals, Inc.
9. Promise and Problems Signal Mixed Year Ahead for Biopharmaceutical Industry, Says Pharmaceutical Executive Magazine
10. Webcast Alert: Isis Pharmaceuticals 2012 Financial Results and Highlights Conference Call
11. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015  PDL BioPharma, Inc. (NASDAQ: PDLI ) ... agreement with CareView Communications, Inc. (OTCQB: CRVW) whereby PDL ... secured debt financing. CareView is an information technology provider ... Under the credit agreement, PDL will provide ... in two tranches of $20 million, based upon the ...
(Date:6/29/2015)... , June 29, 2015  Allergan plc ... intends to release second quarter 2015 financial results ... open of the U.S. financial markets. The Company will ... a.m. Eastern Daylight Time on Thursday, August 6, ... to access the call is U.S./ Canada ...
(Date:6/29/2015)... TARRYTOWN, N.Y. , June 29, 2015 /PRNewswire/ ... today announced that the Proceedings of the ... a paper demonstrating that the Company,s proprietary VelociGene ... the rapid identification and preclinical validation of potential ... and treatment of Middle East Respiratory Syndrome (MERS). ...
Breaking Medicine Technology:PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5
... DURHAM, N.C., May 1, 2012 Heart IT, ... approved zero footprint medical imaging workstation, WebPAX®, announced ... "zero-footprint" medical image viewing technologies. "Zero-footprint" technologies allow ... any computing platform with a standard Internet web ...
... 2012 Amarantus BioSciences, Inc. (OTCBB: AMBS), a ... the treatment of Parkinson,s disease and other nervous ... selected to present in the Emerging Companies Showcase ... Meeting on May 2nd, 2012 in New York ...
Cached Medicine Technology:U.S. Patent Office Issues Sixth Patent Covering 'Zero-Footprint' Medical Image Viewers to Heart Imaging Technologies, LLC 2Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 2Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 3
(Date:6/30/2015)... , ... June 30, 2015 , ... Some may define ... and the ongoing efforts of New York State Athletic Trainers’ Association (NYSATA) and its ... was recognized with two national awards, and a number of members also received honors ...
(Date:6/30/2015)... ... June 30, 2015 , ... The American Psychiatric Nurses ... Disney’s Coronado Springs Resort in Lake Buena Vista, Florida, and will offer more ... event for psychiatric-mental health nursing draws more than 1,500 health care professionals from ...
(Date:6/30/2015)... ... June 30, 2015 , ... Medflow, ... EHR, a SaaS electronic health records system from the company exclusively dedicated to ... Medflow 2.0 delivers an intuitive state-of-the-art solution combining modern cloud technology with Medflow’s ...
(Date:6/30/2015)... ... , ... Scott Purdy, the spokesperson for Dephinitive Systems LLC, announces today that ... the XO stands for eXtra Operability (XO) which was chosen to reflect the company’s ... Cycle. , Provider XO, based in Cleveland OH, is part of the Cadrillion ...
(Date:6/29/2015)... NY (PRWEB) , ... June 30, 2015 , ... ... honors Melanie Richards as a 2015-2016 inductee into its VIP Woman ... in business. NAPW is the nation’s leading networking organization exclusively for professional women, ...
Breaking Medicine News(10 mins):Health News:NYSATA and Members Recognized with National Awards 2Health News:NYSATA and Members Recognized with National Awards 3Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Medflow Launches MEDFLOW 2.0 EHR – The Cloud-Based Ophthalmology EHR 2Health News:Dephinitive Systems Is Getting a New Name 2Health News:National Association of Professional Women Inducts Melanie Richards, DMD, of Powdersville Pediatric Dentistry, Into its VIP Woman of the Year Circle 2
... ... company, launched a new laundry detergent for U.S. consumers concerned about their budget as ... detergent ball contains 10 ounces of macro-molecule laundry detergent which cleans for up to ... than $100 over 200 washes. , ...
... 15 March 2010: Scientists at the University of Liverpool ... for health and wellbeing because they tackle the biological ... of overconsumption and weight gain. Dr Jason Halford, ... Liverpool, points out that anti-obesity drug developers focus primarily ...
... as natural antioxidants is a good way forward for the ... This has been shown by researchers from the Miguel Hernndez ... Researchers from the Miguel Hernndez University have identified cloves ... to the fact they contain high levels of phenolic compounds, ...
... ... doxorubicin delivery embolotherapy microspheres are effective in treating liver cancer, hepatocellular cancer (HCC). ... a clinical study presentation at the Society of Interventional Radiology (SIR) annual meeting. ... ...
... late, survey finds , TUESDAY, March 16 (HealthDay News) ... seriously ill relieve symptoms such as pain, are now ... don,t interact with patients until it,s too late, study ... University of Texas M.D. Anderson Cancer Center in Houston, ...
... ... now purchase ModiFace’s Latest Cosmetic Surgery Imaging System for the equivalent cost of a ... ... of advanced web-based virtual makeover tools, today announced the launch of VuMe, the company’s ...
Cached Medicine News:Health News:Oransi Launches Robby Wash High Efficiency Laundry Detergent in U.S. – 10 Ounces Replaces 75 lbs. of Traditional Laundry Detergent 2Health News:Oransi Launches Robby Wash High Efficiency Laundry Detergent in U.S. – 10 Ounces Replaces 75 lbs. of Traditional Laundry Detergent 3Health News:Anti-obesity drugs unlikely to provide lasting benefit according to scientists 2Health News:Anti-obesity drugs unlikely to provide lasting benefit according to scientists 3Health News:Cloves are the best natural antioxidant 2Health News:BioSphere Medical's HepaSphere Microspheres Safely Deliver Doxorubicin in Liver Cancer Chemoembolization Therapy -- Study Presented at SIR 2Health News:BioSphere Medical's HepaSphere Microspheres Safely Deliver Doxorubicin in Liver Cancer Chemoembolization Therapy -- Study Presented at SIR 3Health News:BioSphere Medical's HepaSphere Microspheres Safely Deliver Doxorubicin in Liver Cancer Chemoembolization Therapy -- Study Presented at SIR 4Health News:Pain Relief Often Delayed for Cancer Patients 2Health News:ModiFace Launches VuMe in Southern Florida – the World's First Full-Featured Touch-Screen Cosmetic Surgery Imaging System 2Health News:ModiFace Launches VuMe in Southern Florida – the World's First Full-Featured Touch-Screen Cosmetic Surgery Imaging System 3
... headboxes are the latest ... of portable battery-powered EEG ... robust new mechanical design, ... XLTEK's standard MOBEE24plus and ...
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
Medicine Products: